International Hepatology Archives - Page 9 of 47

AASLD 2024丨Artificial Intelligence Enhancing Early Diagnosis of Metabolic Associated Steatotic Liver Disease

By Mourabit Halima 2024.11.21

At the 2024 Annual Meeting of the American Association for the Study of Liver Diseases (AASLD) held on November 15 in San Diego, California, a groundbreaking study highlighted the transformative…

Chinese Expertise at AASLD 2024: Dr. Huiguo Ding’s Team Advances Non-Invasive Differentiation of PSVD and Cirrhotic Portal Hypertension Using Machine

By Mourabit Halima 2024.11.21

From November 15–19, 2024, the American Association for the Study of Liver Diseases (AASLD) convened in San Diego, USA. A study led by Dr. Huiguo Ding’s team from the Beijing…

Case Study丨Dr. Jia Shang: Diagnosis and Treatment of Invasive Fungal Infection in Severe Liver Disease Patients

By Mourabit Halima 2024.11.18

Editor's Note: Invasive fungal infection (IFI) refers to a fungal infection that invades the deep tissues and organs of the human body, causing pathological changes such as tissue damage, organ…

Collaboration in HPB Health: Highlights from the 9th Academic Symposium of the Chinese Chapter of IHPBA

By Mourabit Halima 2024.11.14

The 9th Academic Symposium of the Chinese Chapter of the International Hepato-Pancreato-Biliary Association (IHPBA) concluded successfully, underscoring major strides in global HPB collaboration. Hosted by Dr. Lanfei Cheng, the symposium…

$Dr. Ying Han: Early Diagnosis and Intervention Strategies for Refractory Primary Biliary Cholangitis$

Dr. Ying Han: Early Diagnosis and Intervention Strategies for Refractory Primary Biliary Cholangitis

By Peter W. PENG 2024.11.11

Editor’s Note: With shifts in the global landscape of liver diseases, the incidence of primary biliary cholangitis (PBC) has been rising annually. In China, PBC’s prevalence has reached the highest…

Chairman’s Interview | Dr. Shuangsuo Dang: Ten Years on the Road, Exploring New Trends in Hepatology in the Western Regions

By Lisa Cui 2024.11.08

The Silk Road begins in Chang'an, with the sounds of camel bells echoing through history. From October 17 to 19, the 10th "Silk Road Hepatology" Academic Conference was held in…

PNAS丨Dr. Wenshi Wang’s Team from Xuzhou Medical University Unveils Key Molecular Mechanisms of Cross-Species Transmission of Rat HEV

By Peng Longmei 2024.11.07

Hepatitis E virus (HEV) is the leading cause of acute viral hepatitis globally, infecting 20 million people annually and resulting in approximately 60,000 deaths. HEV, part of the Hepeviridae family…

ILCA Chair Interview | Dr. Tim Meyer: Focusing on Advances in Liver Cancer Treatment and Shaping Future Progress

By Lisa Cui 2024.11.06

From October 17 to 19, 2024, in the season of golden autumn, the 18th International Liver Cancer Association (ILCA) Annual Conference was successfully held. This grand event attracted numerous top…

Call for Papers by November 24丨Beijing APASL 2025 Annual Meeting, Inviting Liver Disease Research Experts to Participate

By Peng Longmei 2024.11.04

The highly anticipated 34th Annual Meeting of the Asia-Pacific Association for the Study of the Liver (APASL 2025) will be held in Beijing from March 26 to 30, 2025. This…

ESMO China Voice: Personalized ctDNA Methylation for Monitoring MRD Post-Liver Cancer Resection by Fan Jia, Jian Zhou & Xinrong Yang’s Team

By Lisa Cui 2024.10.28

Amidst the serene morning mist gracing the wutong trees and frost enhancing the ripeness of oranges, the 2024 Annual Meeting of the European Society for Medical Oncology (ESMO) unfolds in…